Wei Li - Shanghai Pulmonary Hospital, Tongji University

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 156 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Circkdm1a Suppresses Bladder Cancer Progression by Sponging Mir-889-3p/cpeb3 and Stabilizing P53 Mrna

Haotian Chen,Jing Wen,Wentao Zhang,Wenchao Ma,Yadong Guo,Liliang Shen,Zhijin Zhang,Fuhan Yang,Yue Zhang,Yaohui Gao,Tianyuan Xu,Yang Yan,Wei Li,Junfeng Zhang,Shiyu Mao,Xudong Yao

ISCIENCE（2024）

引用0浏览0WOS引用

Squamous Cell Carcinoma of Ear and Temporal Bone: A Retrospective Study on Clinicopathological Predictors

Wei Li, Bronwyn Tucker,Zhan-Dong Hu,Yu-Jie Zhang,Xue-Xi Guo,Wen-Juan Cai,Ming-Fang Zhang,Ya-Ting Han

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECKno. 11 (2024): 2870-2877

引用0浏览0WOS引用

Efficacy and Safety of Taletrectinib in Chinese Patients with ROS1+ Non-Small Cell Lung Cancer: the Phase II TRUST-I Study

Wei Li,Anwen Xiong,Nong Yang,Huijie Fan,Qitao Yu,Yanqiu Zhao,Yongsheng Wang,Xue Meng,Jingxun Wu,Ziping Wang,Yunpeng Liu,Xicheng Wang,Xintian Qin,Kaihua Lu,Wu Zhuang, Yizhong Ren, Xianyu Zhang, Bing Yan,Christine M. Lovly,Caicun Zhou

JOURNAL OF CLINICAL ONCOLOGYno. 22 (2024)

引用0浏览0WOS引用

Microbial Tryptophan Metabolites and Gut Epithelial Barrier Function Link the Gut Microbiota to Chemotherapy-Induced Toxicities

Yan Wang,Chen Chen,Wei Li,Zheng-Yan Zhang,Xin Wang,Ya-Yun Xu,Zhi-Ming Wang,Shilong Zhang

crossref（2024）

引用0浏览0引用

Phase I Clinical Study of FC084CSA, a High Selective AXL Kinase Inhibitor That Ameliorates Tumor Microenvironment and Augments the Effectivity of Immunotherapy

Wei Li,Lei Wang,Jing Wang,Zhengbo Song,Qingyuan Zhang,Caicun Zhou

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Exploring the Microbiota Difference of Bronchoalveolar Lavage Fluid Between Community-Acquired Pneumonia with or Without COPD Based on Metagenomic Sequencing: a Retrospective Study

Bingbing Wang,Min Tan,Wei Li, Qinghua Xu, Lianfeng Jin,Shuanshuan Xie,Changhui Wang

BMC PULMONARY MEDICINEno. 1 (2024)

引用0浏览0WOS引用

Probiotics Are Beneficial for Liver Cirrhosis: a Systematic Review and Meta-Analysis of Randomized Control Trials

Xing Yang,Langhuan Lei, Wei Shi, Xiaozhen Li,Xiaozhi Huang,Liuyan Lan,Jiali Lin,Qiuyu Liang,Wei Li,Jianrong Yang

FRONTIERS IN MEDICINE（2024）

引用0浏览0WOS引用

Anti-TNFR2 Monoclonal Antibody LBL-019 in Patients with Advanced Malignant Tumors: A Phase I, First-in-human, Open-Label, Multicenter, Dose Escalation Study

Fei Zhou,Wei Li,Yu Chen,Jing Lin,Ling Chen,Huishan Zhang,Xiaorong Dong,Fan Tong,Ruiguang Zhang,Yongmei Yin,Yan Liang,Nong Yang,Sheng Hu, Wei Zhuang,Tao Li, Shengli Cai,Caicun Zhou

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

A Nomogram for the Prediction of the Survival of Patients with Advanced Non‐small Cell Lung Cancer and Interstitial Lung Disease

Weigang Xiu, Jincheng Zheng,Yuwen Zhou,He Du,Jiayu Li,Wei Li,Fei Zhou,Caicun Zhou,Fengying Wu

CANCER MEDICINEno. 10 (2023): 11375-11384

引用0浏览0WOS引用

P2.14-07 Updated Results of Camrelizumab Plus Nab-Paclitaxel and Carboplatin As First-Line Treatment for ES-SCLC: A Phase II Trial

S. Ren,J. Yu,A. Xiong,Q. Wang, L. Wang,B. Chen, M. Yang,W. Li, J. Yuan, C. Zhao, C. Zhou

Journal of thoracic oncologyno. 11 (2023): S373-S374

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn